Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05329285 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

CABG or PCI in Patients With Ischemic Cardiomyopathy

Study acronym: STICH
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Minor Eligibility criteria expanded, about 17 words
    • Secondary endpoints: details revised at 1 of 5 entries
    • Study description expanded, about 6 words
    • Publications: details revised at 1 of 1 entry
  2. Minor Collaborators expanded, about 9 wordsv6
  3. Notable Primary completion date: Dec 31, 2027 to Dec 31, 2028
    • Study completion date: Dec 31, 2051 to Dec 31, 2052
    • Eligibility criteria expanded, about 65 words
    v5
  4. Notable Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    v4
  5. Minor Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Aug 20, 2022 to Sep 14, 2022
    v3
  6. Notable Start date: Apr 20, 2022 to Aug 20, 2022v2
  7. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The STICH-SWEDEHEART trial will compare PCI vs CABG for revascularization of patients with HF and LV systolic dysfunction (LV ejection fraction (LVEF) \<40%) and multi-vessel coronary artery disease.
Trial Details
NCT Number NCT05329285
Lead Sponsor Vastra Gotaland Region
Collaborators: Region Örebro County, Karolinska University Hospital, University Hospital, Umeå
Conditions
(from sponsor)
Coronary Artery Disease
Related terms Coronary Artery Disease
Enrollment 470 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov